This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
New data from the MOTheR trial1, one of the most rigorous head-to-head studies of advanced dialysis therapies to date, marks an important step forward in how the kidney care community approaches treatment for patients with end stage kidney disease. Presented at the European Renal Association (ERA) Congress in June 2026, the prospective randomized controlled trial […]
The journey to receiving a kidney transplant can be a complex and deeply emotional experience. To navigate the intricate path that includes education, care coordination and personal support, patients often rely on their multidisciplinary care teams as they work to reach this life-changing milestone. DaVita teammates — from facility administrators and social workers to patient […]
While kidney transplant is the optimal treatment path for end stage kidney disease (ESKD), complex logistical, financial and educational barriers can often stand in the way for many patients interested in pursuing it. The process can require rigorous medical, financial and emotional preparation. Clinical social workers help with this. In addition to guiding patients to […]
“The secret of the care of the patient is in caring for the patient.”¹ None of us would ever choose to have kidney failure. And that is exactly why innovations that help patients feel better and live healthier are critical to our work serving the kidney community. Middle molecule clearance is emerging as a meaningful […]
For U.S. healthcare systems, clinical and financial stability can be achieved when we look beyond treatment options for individual disease states and instead take a more holistic approach that also addresses the pathological mechanisms that extend across multiple disease states. The American Heart Association definition of the cardiovascular-kidney-metabolic syndrome (CKM syndrome), a systemic overlap of […]